Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. 2008

Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
Inserm UMR-S 839, Paris, France.

Psychostimulants and other drugs of abuse activate extracellular signal-regulated kinase (ERK) in the striatum, through combined stimulation of dopamine D(1) receptors (D1Rs) and glutamate NMDA receptors. Antipsychotic drugs activate similar signaling proteins in the striatum by blocking dopamine D(2) receptors (D2Rs). However, the neurons in which these pathways are activated by psychotropic drugs are not precisely identified. We used transgenic mice, in which enhanced green fluorescent protein (EGFP) expression was driven by D1R promoter (drd1a-EGFP) or D2R promoter (drd2-EGFP). We confirmed the expression of drd1a-EGFP in striatonigral and drd2-EGFP in striatopallidal neurons. Drd2-EGFP was also expressed in cholinergic interneurons, whereas no expression of either promoter was detected in GABAergic interneurons. Acute cocaine treatment increased phosphorylation of ERK and its direct or indirect nuclear targets, mitogen- and stress-activated kinase-1 (MSK1) and histone H3, exclusively in D1R-expressing output neurons in the dorsal striatum and nucleus accumbens. Cocaine-induced expression of c-Fos and Zif268 predominated in D1R-expressing neurons but was also observed in D2R-expressing neurons. One week after repeated cocaine administration, cocaine-induced signaling responses were decreased, with the exception of enhanced ERK phosphorylation in dorsal striatum. The responses remained confined to D1R neurons. In contrast, acute haloperidol injection activated phosphorylation of ERK, MSK1, and H3 only in D2R neurons and induced c-fos and zif268 predominantly in these neurons. Our results demonstrate that cocaine and haloperidol specifically activate signaling pathways in two completely segregated populations of striatal output neurons, providing direct evidence for the selective mechanisms by which these drugs exert their long-term effects.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
May 2007, Trends in neurosciences,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
October 2020, Proteomes,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
September 1993, Brain research,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
February 2022, Current biology : CB,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
October 2018, Molecular neurobiology,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
October 2013, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
June 1996, The Journal of comparative neurology,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
May 2012, Neuroscience letters,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
December 2012, Hippocampus,
Jesus Bertran-Gonzalez, and Clémentine Bosch, and Matthieu Maroteaux, and Miriam Matamales, and Denis Hervé, and Emmanuel Valjent, and Jean-Antoine Girault
March 2018, Addiction biology,
Copied contents to your clipboard!